Aveanna Healthcare Holdings Inc. (AVAH) – What Are Researchers Saying About This Stock?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been given an average rating of “Moderate Buy” by the eleven analysts that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $14.25.

A number of analysts have recently issued reports on the company. Wall Street Zen raised Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Barclays upped their target price on Aveanna Healthcare from $9.50 to $15.00 and gave the company an “overweight” rating in a research report on Friday, August 28th. JPMorgan Chase & Co. upped their price target on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, September 14th. Royal Bank Of Canada reissued an “outperform” rating on shares of Aveanna Healthcare in a research report on Friday. Finally, Raymond James Financial reaffirmed a “strong-buy” rating on shares of Aveanna Healthcare in a research report on Thursday.

Aveanna Healthcare Stock Down 6.0%

Shares of NASDAQ AVAH traded down $0.74 during trading on Friday, reaching $11.50. 4,266,299 shares of the stock were exchanged, compared to its average volume of 2,149,174. The company has a market capitalization of $2.51 billion, a price-to-earnings ratio of 8.39, a price-to-earnings-growth ratio of 0.75 and a beta of 2.03. The business’s 50-day moving average price is $13.02 and its 200 day moving average price is $9.46. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare has a twelve month low of $5.93 and a twelve month high of $14.71.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, November 12th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.02. Aveanna Healthcare had a net margin of 11.44% and a return on equity of 70.01%. The firm had revenue of $695.54 million for the quarter, compared to the consensus estimate of $679.48 million. As a group, equities analysts forecast that Aveanna Healthcare will post 0.77 EPS for the current fiscal year.

Recent Aveanna Healthcare Headlines

These are some of the AVAH headlines that stood out recently:

• Positive Sentiment: Third-quarter adjusted earnings were $0.23 per share, above the $0.21 consensus and up from $0.15 a year earlier. Revenue of $695.54 million also topped estimates of $679.48 million. Aveanna Healthcare Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Aveanna raised its 2026 guidance; its revenue outlook is $2.7 billion, broadly in line with consensus. Investors may also see potential support from growth and operational efficiencies, as well as a planned California rate increase in 2027. Aveanna Healthcare: Revenue Growth, Guidance Raises, Yet Shares Still Trade At A Discount
• Negative Sentiment: The company froze a planned California nurse base-wage increase amid uncertainty around state reimbursement rates. Wage pressure and uncertainty over when rate increases will take effect could constrain margins. Aveanna Freezes California Nurse Base Wage Hike Amid Rate Uncertainty

Insider Activity at Aveanna Healthcare

In other news, major shareholder Paul Vigano sold 14,500,002 shares of Aveanna Healthcare stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $166,750,023.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $143,704,885.50. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 48,566,081 shares of company stock worth $558,509,932 over the last quarter. 5.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aveanna Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the business. Sterling Capital Management LLC grew its holdings in shares of Aveanna Healthcare by 398.3% during the third quarter. Sterling Capital Management LLC now owns 2,636 shares of the company’s stock valued at $33,000 after purchasing an additional 2,107 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Aveanna Healthcare by 217.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 2,978 shares of the company’s stock worth $37,000 after purchasing an additional 2,039 shares during the last quarter. C M Bidwell & Associates Ltd. acquired a new position in Aveanna Healthcare during the 2nd quarter valued at approximately $69,000. Freestone Grove Partners LP acquired a new position in Aveanna Healthcare during the 2nd quarter valued at approximately $73,000. Finally, GK Wealth Management LLC bought a new stake in Aveanna Healthcare in the third quarter valued at $90,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.